In the context of AML cases harboring nucleophosmin 1 (NPM1) mutations 45, HOXB-AS3 assumes a regulatory role in the proliferative capacity of blasts, which are undifferentiated leukemia cells. This evidence concerns the gene NPM1 and leukemia.